Ecoks Capsule 7.5 mg (Meloxicam)

Adult dose

1. For acute exacerbations of osteoarthritis (degenerative arthritis): ○ Adults: Administer 7.5 mg of meloxicam orally once daily. If symptoms do not improve, the dose may be increased to up to 15 mg daily as needed. 2. Rheumatoid arthritis, ankylosing spondylitis: ○ Adults: Administer 15 mg of this medicine orally once daily. The dose may be reduced to 7.5 mg daily according to the response to treatment. This medicine should not be administered at doses exceeding 15 mg daily and should be taken with water or another beverage during meals. ○ In elderly patients or those at increased risk of adverse reactions, treatment is usually started at a dose of 7.5 mg daily. ○ Patients with severe renal impairment receiving hemodialysis should not receive more than 7.5 mg daily.

This medication should be used only after consulting a doctor or pharmacist for individuals who regularly consume more than three alcoholic beverages daily, as there is a risk of gastrointestinal bleeding from taking this medication. Non-steroidal anti-inflammatory drugs, including this medication, can cause heart and vascular issues, particularly increasing the risk of serious cardiovascular diseases such as myocardial infarction or stroke, so individuals with cardiovascular diseases or risk factors should exercise caution. This medication can cause gastrointestinal issues which may lead to severe adverse reactions such as gastrointestinal bleeding, ulcers, or perforation. Extra caution is advised for those with a history of gastrointestinal diseases, elderly individuals, and those taking anticoagulants. Serious allergic skin reactions may occur, so if symptoms such as skin rash or mucosal damage appear, discontinue the medication immediately. This medication can also affect kidney function, so those with kidney disease or weakened kidney function should exercise caution. Individuals with liver function impairment should have regular liver function tests while taking this medication to monitor for adverse reactions. Women planning to become pregnant or who are pregnant should not take this medication as it may reduce reproductive capacity. This medication should not be administered to individuals with certain genetic disorders, including lactose intolerance, so it is important to disclose such conditions. This medication has many interactions with other drugs, especially anticoagulants, lithium, methotrexate, diuretics, and antihypertensives, so it should be used carefully with a doctor's consultation. Elderly individuals may have impaired liver, kidney, or heart function, so they should use the minimum effective dose cautiously and closely monitor for adverse reactions. In cases of overdose, symptoms such as drowsiness, nausea, vomiting, and gastrointestinal bleeding may occur; in severe instances, serious side effects such as heart problems, kidney failure, or liver failure may arise, requiring immediate medical attention. This medication should be stored out of reach of children and kept sealed in its original container for safety.

• Gastrointestinal bleeding
• cardiovascular thrombotic events
• myocardial infarction
• stroke
• gastrointestinal or intestinal bleeding
• ulcers
• perforation
• erosive dermatitis
• mucocutaneous syndrome
• toxic epidermal necrolysis

This medication is sensitive to light and should be stored in a special container that blocks light. Additionally, it should be kept at room temperature, not too hot or too cold, ideally between 1 to 30 degrees Celsius, to maintain its effectiveness and safety.

Appearance

A hard capsule with a yellow powder, upper part greenish, lower part light green.

Package unit

30 capsules/bottle, 100 capsules/bottle